Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
214
-
Total 13F shares, excl. options
-
89.2M
-
Shares change
-
+290K
-
Total reported value, excl. options
-
$1.55B
-
Value change
-
+$5.23M
-
Put/Call ratio
-
0.64
-
Number of buys
-
99
-
Number of sells
-
-111
-
Price
-
$17.40
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q3 2020
266 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q3 2020.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 214 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.2M shares
of 106M outstanding shares and own 84.26% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15.1M shares), VANGUARD GROUP INC (11.7M shares), RENAISSANCE TECHNOLOGIES LLC (9.61M shares), INGALLS & SNYDER LLC (7.49M shares), FEDERATED HERMES, INC. (5.2M shares), STATE STREET CORP (3.17M shares), DIMENSIONAL FUND ADVISORS LP (2.6M shares), Invesco Ltd. (2.32M shares), LSV ASSET MANAGEMENT (1.58M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.51M shares).
This table shows the top 214 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.